Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.

Saved in:
Bibliographic Details
Title: Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.
Authors: Mukohara T; National Cancer Center Hospital East, Kashiwa, Japan., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Sommerhalder D; NEXT Oncology, San Antonio, TX, USA., Yonemori K; National Cancer Center Hospital, Tokyo, Japan., Hamilton E; Sarah Cannon Research Institute, Nashville, TN, USA., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim JH; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Iwata H; Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan., Yamashita T; Kanagawa Cancer Center, Yokohama, Japan., Layman RM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mita M; Hoag Family Cancer Institute, Newport Beach, CA, USA., Clay T; Saint John of God Subiaco Hospital, Perth, Western Australia, Australia., Chae YS; Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Oakman C; Western Health, Sunshine Hospital, St Albans, Victoria, Australia., Yan F; Swedish Cancer Institute, First Hill-True Family Women's Cancer Center, Seattle, WA, USA., Kim GM; Yonsei University College of Medicine, Seoul, Republic of Korea., Im SA; Seoul National University Hospital, Seoul National University College of Medicine, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lindeman GJ; Peter MacCallum Cancer Centre and Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Rugo HS; University of California, San Francisco, CA, USA., Liyanage M; Pfizer, San Diego, CA, USA., Saul M; Pfizer, San Diego, CA, USA., Le Corre C; Pfizer, San Diego, CA, USA., Skoura A; Pfizer, Collegeville, PA, USA., Liu L; Pfizer, San Diego, CA, USA., Li M; Pfizer, San Francisco, CA, USA. meng.li7@pfizer.com., LoRusso PM; Yale School of Medicine, New Haven, CT, USA. patricia.lorusso@yale.edu.
Source: Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2371.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-024-03129-w